Most doses of Eli Lilly’s highly popular weight loss drug Zepbound and diabetes counterpart Mounjaro will be in short supply through the second quarter of this year as demand jumps, according to an u… [+2150 chars]Read More
Most doses of Eli Lillys Zepbound Mounjaro in short supply through June FDA says CNBC
